Q3 2025 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our quarterly pharmaceutical industry review, we’re pleased to share an update on merger and acquisition activity…
Q2 2025 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…
Q1 2025 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…
Q4 2024 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…
Q3 2024 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…
Q2 2024 M&A Update
The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to…